These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39240166)

  • 1. Impact of thoracic radiotherapy on first-line treatment outcomes in ES-SCLC patients.
    Mu X; Zhou Y; Liu Q; Wang J; Xu F; Luo F; Wang K; Li L; Tian P; Li Y; Liu J; Zhang Y; Liu J; Li Y
    Cancer Med; 2024 Sep; 13(17):e70175. PubMed ID: 39240166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
    Han J; Fu C; Li B
    Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    Dang J; Xu G; Guo G; Zhang H; Shang L
    J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis.
    Yao Y; Li B; Song R; Yang L; Zou B; Wang L
    Radiat Oncol; 2024 Feb; 19(1):25. PubMed ID: 38413988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six versus four or five cycles of first-line etoposide and platinum-based chemotherapy combined with thoracic radiotherapy in patients with limited-stage small-cell lung cancer: A propensity score-matched analysis of a prospective randomized trial.
    Yu TT; Hu X; Liufu WJ; Niu SQ; Lian HM; Ma HL; Wang J; Bao Y; Chen M; Peng F
    Cancer Med; 2024 Apr; 13(8):e7215. PubMed ID: 38659392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
    Tian S; Zhang X; Jiang R; Pillai RN; Owonikoko TK; Steuer CE; Saba NF; Pakkala S; Patel PR; Belani CP; Khuri FR; Curran WJ; Ramalingam SS; Behera M; Higgins KA
    Clin Lung Cancer; 2019 Nov; 20(6):484-493.e6. PubMed ID: 31296433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy.
    Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer.
    Peng J; Zhang L; Wang L; Feng H; Yao D; Meng R; Liu X; Li X; Liu N; Tan B; Huang Z; Li S; Meng X
    Radiat Oncol; 2023 Jul; 18(1):111. PubMed ID: 37403111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and synergistic effect between radiotherapy and immunotherapy in patients with extensive-stage small cell lung cancer: a real-world study.
    Sun M; Ji H; Deng F; Li J; Xu N; Li Y
    BMC Cancer; 2024 Sep; 24(1):1206. PubMed ID: 39350057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
    Bayman E; Etiz D; Akcay M; Ak G
    Asian Pac J Cancer Prev; 2014; 15(15):6263-7. PubMed ID: 25124609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can consolidative thoracic radiotherapy improve outcomes in extensive-disease small cell lung cancer after chemotherapy with complete/near-complete responders?
    Kirakli EK; Yilmaz H; Akcay C; Komurcuoglu B; Yilmaz U
    J Cancer Res Ther; 2020; 16(4):752-756. PubMed ID: 32930114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
    Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.
    Slotman BJ; Faivre-Finn C; van Tinteren H; Keijser A; Praag J; Knegjens J; Hatton M; van Dam I; van der Leest A; Reymen B; Stigt J; Haslett K; Tripathi D; Smit EF; Senan S
    Lung Cancer; 2017 Jun; 108():150-153. PubMed ID: 28625628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world.
    Fang M; Wang L; Gu Q; Wu H; Du X; Lai X
    Clin Exp Metastasis; 2023 Oct; 40(5):423-429. PubMed ID: 37584783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral NK cells identified as the predictor of response in extensive-stage small cell lung cancer patients treated with first-line immunotherapy plus chemotherapy.
    Cui Y; Chen Y; Zhao P; Li S; Cheng Y; Ren X
    Clin Transl Oncol; 2024 Oct; 26(10):2522-2530. PubMed ID: 38662170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation.
    Zhang H; Deng L; Wang X; Wang D; Teng F; Yu J
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2605-2612. PubMed ID: 31410604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer.
    Li-Ming X; Zhao LJ; Simone CB; Cheng C; Kang M; Wang X; Gong LL; Pang QS; Wang J; Yuan ZY; Wang P
    Radiother Oncol; 2017 Nov; 125(2):331-337. PubMed ID: 29079309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.
    Xu LM; Cheng C; Kang M; Luo J; Gong LL; Pang QS; Wang J; Yuan ZY; Zhao LJ; Wang P
    Sci Rep; 2017 Aug; 7(1):9255. PubMed ID: 28835666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of PD-1/PD-L1 inhibitor plus chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small cell lung cancer: A systematic review and meta-analysis.
    Zhang S; Li S; Cheng Y
    Thorac Cancer; 2020 Dec; 11(12):3536-3546. PubMed ID: 33058504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer.
    Wang H; Yao Z; Kang K; Zhou L; Xiu W; Sun J; Xie C; Yu M; Li Y; Zhang Y; Zheng Y; Lin G; Pan X; Wu Y; Luo R; Wang L; Tang M; Liao S; Zhu J; Zhou X; Zhang X; Xu Y; Liu Y; Peng F; Wang J; Xiang L; Yin L; Deng L; Huang M; Gong Y; Zou B; Wang H; Wu L; Yuan Z; Bi N; Fan M; Xu Y; Tong R; Yi L; Gan L; Xue J; Mo X; Chen C; Na F; Lu Y
    Med; 2024 Oct; 5(10):1237-1254.e9. PubMed ID: 38964333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.